Talphera TLPH
NASDAQ TLPH
$1.24 +0.01 (+1.23%)
As of: Sep 10, 2026 · 1:39 PM EDT

Talphera (TLPH) Operating Expenses (2010 - 2026)

Talphera (TLPH) posted Operating Expenses of $3.9 million for Q2 2026, down 0.61% on a QoQ basis from $3.9 million in Q1 2026, and up 6.26% year-over-year from $3.7 million in Q2 2025.

Analysis

Talphera (TLPH) Operating Expenses (2010 - 2026) Analysis & Trends

Talphera has reported Operating Expenses for 17 years, with the latest figure at $3.9 million in Q2 2026.

  • On a quarterly basis, Operating Expenses rose 6.26% year-over-year to $3.9 million in Q2 2026; TTM through Jun 2026 was $14.7 million, a 10.22% increase from a year earlier, with the FY2025 full-year figure at $13.5 million, down 11.41% from the prior year.
  • Operating Expenses was $3.9 million for Q2 2026 at Talphera, down from $3.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $10.0 million in Q2 2022, with the low at $2.9 million in Q1 2025.
  • Average Operating Expenses over 5 years is $4.6 million, with a median of $3.9 million recorded in 2026.
  • The sharpest annual moves came in 2023 and 2026: Operating Expenses sank 57.59% in 2023, then surged 34.15% in 2026.
  • Over 5 years, Operating Expenses stood at $5.9 million in 2022, then retreated by 22.46% to $4.6 million in 2023, then plunged by 34.36% to $3.0 million in 2024, then gained by 15.25% to $3.5 million in 2025, then increased by 13.64% to $3.9 million in 2026.
  • The last three Operating Expenses figures came in at $3.9 million (Q2 2026), $3.9 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.67 Bn 192.69 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.06 Bn 176.88 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 131.44 Bn 123.59 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.94 Bn 73.95 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.87 Bn 48.73 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.15 Bn 29.85 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.88 Bn 30.60 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.16 Bn 29.16 Bn 1.16 Mn 367.83 Mn
10 Talphera 93.28 Mn 93.28 Mn - 3.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.92 Mn
Mar 31, 2026 3.95 Mn
Dec 31, 2025 3.45 Mn
Sep 30, 2025 3.42 Mn
Jun 30, 2025 3.69 Mn
Mar 31, 2025 2.94 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 3.75 Mn
Jun 30, 2024 4.27 Mn
Mar 31, 2024 4.24 Mn
Dec 31, 2023 4.56 Mn
Sep 30, 2023 3.43 Mn
Jun 30, 2023 4.22 Mn
Dec 31, 2022 5.89 Mn
Sep 30, 2022 4.52 Mn
Jun 30, 2022 9.96 Mn
Mar 31, 2022 9.44 Mn
Dec 31, 2021 8.18 Mn
Sep 30, 2021 10.50 Mn
Jun 30, 2021 10.46 Mn